GlassScriptPhysician profile
Heather Riester
NPI 1518395235
$700.00
in general payments reported to CMS, 2019-2025
16 companies · $197 in 2025
The $197 reported for 2025 was more than what 80% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.09 · 2022: $222 · 2023: $47.60 · 2024: $211 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $125.53 | 2024-2025 | |
| Organon LLC | $82.76 | 2023-2025 | Nexplanon |
| Abbvie INC. | $75.93 | 2022 | |
| Therapeuticsmd, INC. | $71.52 | 2022 | |
| Astellas Pharma US INC | $55.00 | 2024 | Veozah |
| Biogen, INC. | $54.05 | 2024-2025 | Zurzuvae |
| Scynexis, INC. | $49.73 | 2022 | |
| Daiichi Sankyo INC. | $25.12 | 2022 | |
| Exeltis, USA INC. | $23.97 | 2024 | Slynd |
| Hologic Sales and Service, LLC | $23.00 | 2025 | Aptima |
| Evofem Biosciences, INC. | $22.09 | 2021 | |
| Millicent US INC | $21.67 | 2024 | Femring, Intrarosa |
| Novo Nordisk INC | $21.42 | 2023 | Wegovy |
| Amgen INC. | $17.94 | 2024 | Evenity, Prolia |
| Sumitomo Pharma America, INC. | $17.04 | 2024 | Myfembree |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $13.23 | 2023 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Riester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.